179 related articles for article (PubMed ID: 34538431)
1. The Penetrance of Topical Nail Therapy: Limitations and Current Enhancements.
Phan K; Kaur K; Wright K; Tran S; Stewart B; Brown M; Vlahovic TC
Clin Podiatr Med Surg; 2021 Oct; 38(4):535-540. PubMed ID: 34538431
[TBL] [Abstract][Full Text] [Related]
2. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
[TBL] [Abstract][Full Text] [Related]
3. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
4. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
Gupta AK; Pillai R
J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
[TBL] [Abstract][Full Text] [Related]
5. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
6. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
7.
Kubota-Ishida N; Takei-Masuda N; Kaneda K; Nagira Y; Chikada T; Nomoto M; Tabata Y; Takahata S; Maebashi K; Hui X; Maibach HI
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084749
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis.
Gupta AK; Polla Ravi S; Choi SY; Konda A; Cooper EA
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):243-255. PubMed ID: 36196052
[TBL] [Abstract][Full Text] [Related]
9. Routes of drug delivery into the nail apparatus: Implications for the efficacy of topical nail solutions in onychomycosis.
Gupta AK; Simpson FC
J Dermatolog Treat; 2016; 27(1):2-4. PubMed ID: 25983025
[TBL] [Abstract][Full Text] [Related]
10. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
11. Topical application of acidified nitrite to the nail renders it antifungal and causes nitrosation of cysteine groups in the nail plate.
Finnen MJ; Hennessy A; McLean S; Bisset Y; Mitchell R; Megson IL; Weller R
Br J Dermatol; 2007 Sep; 157(3):494-500. PubMed ID: 17627796
[TBL] [Abstract][Full Text] [Related]
12. Tavaborole for the treatment of onychomycosis.
Elewski BE; Tosti A
Expert Opin Pharmacother; 2014 Jul; 15(10):1439-48. PubMed ID: 24856836
[TBL] [Abstract][Full Text] [Related]
13. Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
Endringer Pinto F; Bagger C; Kunze G; Joly-Tonetti N; Thénot JP; Osman-Ponchet H; Janfelt C
Mycoses; 2020 Aug; 63(8):869-875. PubMed ID: 32406142
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery to the nail: therapeutic options and challenges for onychomycosis.
Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
Crit Rev Ther Drug Carrier Syst; 2014; 31(6):459-94. PubMed ID: 25271773
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Kawai M
Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
[TBL] [Abstract][Full Text] [Related]
17. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
18. Chemical and physical strategies in onychomycosis topical treatment: A review.
Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
[TBL] [Abstract][Full Text] [Related]
19. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
[TBL] [Abstract][Full Text] [Related]
20. Recent progress on the topical therapy of onychomycosis.
Alley MR; Baker SJ; Beutner KR; Plattner J
Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]